Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Protagenic Therapeutics, Inc. (PTIX)

1.95   0.27 (16.07%) 03-24 15:57
Open: 1.74 Pre. Close: 1.68
High: 2.29 Low: 1.66
Volume: 107,747 Market Cap: 8(M)

Technical analysis

as of: 2023-03-24 4:29:02 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 2.67     One year: 3.12
Support: Support1: 1.06    Support2: 0.31
Resistance: Resistance1: 2.28    Resistance2: 2.67
Pivot: 0.58
Moving Average: MA(5): 0.97     MA(20): 0.54
MA(100): 0.51     MA(250): 0.63
MACD: MACD(12,26): 0.1     Signal(9): 0
Stochastic oscillator: %K(14,3): 82     %D(3): 63
RSI: RSI(14): 93.4
52-week: High: 2.28  Low: 0.31
Average Vol(K): 3-Month: 28 (K)  10-Days: 55 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ PTIX ] has closed above the upper band by 18.7%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 1080.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.29 - 2.3 2.3 - 2.31
Low: 1.64 - 1.65 1.65 - 1.66
Close: 1.94 - 1.95 1.95 - 1.96

Company Description

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.

Headline News

Fri, 24 Mar 2023
Healthcare Stocks Moving Friday: ECOR, RBOT, PTIX, PROK, CDTX, YS, NCNA, EAR - InvestorsObserver

Thu, 23 Mar 2023
Why Block Shares Are Trading Lower By Over 13%? Here Are Other ... - UK

Wed, 22 Mar 2023
PROTAGENIC THERAPEUTICS, INC.NEW : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) -

Wed, 22 Mar 2023
Protagenic Therapeutics to Effect 1-for-4 Reverse Stock Split - Digital Journal

Mon, 17 Oct 2022
The 1001 Imploded Stocks of 2022 (Down 80% or More)… So Far - WOLF STREET

Mon, 10 May 2021
Market Update: The 10 Most Volatile Stocks Today - Nasdaq

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 17 (M)
Shares Float 13 (M)
% Held by Insiders 21.2 (%)
% Held by Institutions 9 (%)
Shares Short 4 (K)
Shares Short P.Month 1 (K)

Stock Financials

EPS -0.25
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.11
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -23.7
Return on Equity (ttm) -43.4
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0
Operating Cash Flow -2 (M)
Levered Free Cash Flow -1 (M)

Stock Valuations

PE Ratio -7.9
PEG Ratio 0
Price to Book value -17.73
Price to Sales 0
Price to Cash Flow -15.19

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2016-07-26
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.